Jan 29 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* PHASE 1B STUDY OF BTX 1503 IN PATIENTS WITH MODERATE TO SEVERE ACNE MET ALL DESIGNATED ENDPOINTS
Jan 29 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* PHASE 1B STUDY OF BTX 1503 IN PATIENTS WITH MODERATE TO SEVERE ACNE MET ALL DESIGNATED ENDPOINTS